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Abstract: Background and Objectives: Skeletal muscles are considered to be the main source of circulating
irisin, both at rest and during physical activity. The aim of this study was to investigate the connection
between irisin, body composition, and energy metabolism in humans. Materials and Methods: Serum
irisin concentrations before and after acute aerobic exercise on a treadmill in 84 healthy adults were
measured and their association with body composition and energy expenditure (EE) (obtained from
indirect calorimetry) was determined. Results: The total pre-exercise irisin concentrations in males and
females were similar, but higher in females when expressed per body mass kg (p < 0.001). There was
an association between pre-exercise irisin per body mass kg, visceral fat rating (rho = −0.52, p = 0.001),
and lean tissue % (rho = 0.41, p < 0.05) in males and lean body mass index (LBMI) (rho = −0.59,
p < 0.001) in females. The pre-exercise irisin concentration correlated with the resting metabolic rate
(RMR) in both sexes (rho = 0.44 in males, rho = 0.36 in females; p < 0.05), but with walking, running,
and the EE difference from RMR in running (∆ running EE) in males only (rho = 0.32 to 0.37, p < 0.05).
There was no significant change in irisin concentration after exercise in 58% of participants, while it
decreased in 23%, and increased in 19%. In male subjects with no change in irisin concentration after
exercise, running (p < 0.05) and ∆ running EE per body mass kg (p < 0.05) were higher than in those
with decreased irisin concentration. Conclusions: These findings indicate that the association of irisin
concentration with body composition and EE parameters has sex-dependent differences, and acute
exercise can lead to various changes in post-exercise irisin levels.
Keywords: irisin; healthy adults; physical exercise; resting metabolic rate; energy expenditure;
body composition
1. Introduction
Irisin is a 112 amino acid peptide produced from its precursor transmembrane protein, fibronectin
type III domain containing protein 5 (FNDC5), following the action of proteases. Irisin is a peroxisome
proliferator-activated receptor (PPAR) γ coactivator 1α (PGC1α) dependent myokine that was initially
discovered by Boström and colleagues in 2012 [1].
The majority of studies relate the function of irisin to subcutaneous fat browning and increased
uncoupling protein 1 expression in adipose tissue, as well as to expression of glucose transporter-4
in muscles due to exercise and shivering thermogenesis [2,3]. The role of irisin in skeletal muscle
metabolism is thought to be related to regulation of the genes associated with the determination of
the energetic reactions of cells [4]. Recently, an irisin receptor was identified through which bone
remodeling and thermogenesis effects are mediated, clarifying the underlying mechanisms of irisin [5].
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Studies in human and animal models describe irisin as a potential biomarker, as well as a protective
and therapeutic agent in case of cardiac muscle, liver, brain, pancreas, bone, and ovary diseases [6–11].
In skeletal muscles, among the genes of which expression can be stimulated by physical exercise
is the FNDC5 gene, and the exercise effect on the irisin level has been investigated in several studies.
One study, conducted with the aim to validate whether the data on irisin function in rodents could be
extrapolated to humans [12] failed to detect FNDC5 gene activation in human muscle biopsies after
10–11 weeks training and observed no effect of irisin or its precursor, recombinant FNDC5, on the
brightening of primary human adipocytes. However, it is still thought that the secretion of irisin is
influenced by physical activity (PA) and many exercise studies examining irisin are ongoing.
Studies on irisin level changes after long-term training reported various results, such as increase
in circulating irisin after 10 and 12 weeks of aerobic training [1,13], no significant changes [14–16], or a
decrease in irisin concentration [17].
Current data on the impact of acute exercise on irisin secretion are inconsistent. A meta-analysis of
10 purposely selected studies concluded that the irisin level increases by approximately 15% in response
to acute resistance or aerobic exercise lasting at least 10 min [18], while in a study performed in Finland
in adult men, there was no significant difference in irisin levels after one hour low intensity aerobic
or heavy intensity exercise session [19]. In another study, after the strength training no immediate
changes were observed, but after the endurance session the irisin level increased immediately [20].
Tsuchiya and colleagues demonstrated that after a single bout of exercise there was a decrease of
irisin level immediately after the low intensity exercise, but no significant change as a result of the
high intensity exercise [21]. In a study by Daskalopoulou et al. the irisin level changed following
two different intensity exercises, with the highest increase after the maximal workload on a cycle
ergometer [22]. Furthermore, studies found an increase in the irisin level immediately after short bout
of cycling and running in healthy adults [14,23], but in the sample collected 10 min after exhausting
cycling irisin level returned to baseline [23].
Although the highest concentration of irisin is found in the skeletal muscles [15], it can be
produced in a variety of tissues. Published data about the association of circulating irisin level with
body composition parameters in adults are inconsistent. Some studies have demonstrated higher
irisin levels in individuals with higher body weight, BMI, and fat mass [24–26], and in subjects with
a normal BMI but increased fat percent [27]. Moreno-Navarrete et al. found lower levels of irisin in
overweight and obese individuals [28]. The concentration of irisin was also positively associated with
bicep circumference, fat free mass [15], and lean body mass for both sexes [14].
In tissue metabolism, irisin stimulates metabolic activity of fat tissue and increases uncoupling
protein 1 (UCP1) in the mitochondrial membrane; this functions to permit proton diffusion back
to the mitochondrial matrix without concomitant ATP synthesis, which in turn stimulates cellular
respiration and expands more energy to pump protons and restore the proton gradient across the
inner mitochondrial membrane. Although this process increases oxygen consumption, the energy
that is obtained mainly dissipates as heat [1]. Irisin also increases the basal metabolic activity of
skeletal muscle cells in vitro following 24 h of irisin treatment, as well as increasing mitochondrial
oxygen consumption during chemically induced peak oxidative metabolism [3]. Moreover, irisin also
stimulates expression of genes that mediate an increase in fat and muscle metabolism [1,3]. A positive
relationship of irisin with calculated RMR in females with different BMIs was found in the work of
Pardo et al. [26], and the association of RMR with irisin concentration in blood is not well characterized
in males. Swick used calorimetrically determined daily energy expenditure for postmenopausal
women and found that the irisin level correlation with energy expenditure was only true for subjects
with greater energy expenditure than those predicted from calculations using FFM [29].
2. Materials and Methods
The aim of this study was to add to currently limited knowledge about connection of irisin and
energy metabolism in humans, to measure the circulating levels of irisin in the blood of healthy adults
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at rest and immediately after an acute aerobic exercise bout. The study involved the participants of
both sexes in order to analyze the concentration of circulating irisin in relation to body fat, lean tissue,
energy metabolism at rest and during exercise, and to compare the results in males and females.
2.1. Study Subjects
The study subjects were 86 adult volunteers of both sexes who met the following inclusion criteria:
age 20–50 years, healthy (no acute or chronic medical conditions), and not using any medication during
the study. The study was approved by the Ethics Committee of Riga Stradins University, and informed
consent was provided by each participant upon study entry, No. 14/31.10.2013, 31 of October 2013.
2.2. Body Composition and Metabolism Measurements
To obtain more precise results, participants arrived in the laboratory in the morning after an
overnight fast with limited PA before the test. All measures of the study protocol were performed
on the same day between 8:00 a.m. and 10:00 a.m. First, the body height of each participant was
measured to the nearest 1.0 cm and a Tanita MC-180 MA (Tanita Corp., Tokyo, Japan) multi-frequency
bioimpedance analyzer was used to measure body mass and assess body composition, including
fat and muscle mass segmental distribution in each extremity and trunk. The visceral fat level was
determined and expressed as a rating. According to the assessment criteria defined by the device
manufacturer, a rating 1 to 12 indicates a healthy level, while 13 and higher indicates an excess level of
visceral fat. The BMI and lean body mass index (LBMI) were also calculated.
RMR determination and exercise tests were conducted, during which energy metabolism was
monitored with indirect calorimetry, and respiratory gas analysis was performed on a breath-by-breath
basis using a gas analysis system (Oxycon Pro, Carefusion, Germany). RMR measurements were
performed in subjects remaining in the supine position, considering the guidelines for measurement
of RMR in healthy adults [30]. From 30 min of data, the results of the initial 5 min were discarded,
and the coefficient of variation (COV) for VO2 and VCO2 of the remaining period was calculated to
determine if a steady state was achieved. The 5-minute period with the lowest (≤10%) COV was used
to calculate the RMR.
Participants then performed 5 min of walking and running bouts on a treadmill with constant
speeds of 4 and 8 km/h, respectively. The consecutive 60-second period with the lowest COV (≤10%)
for VO2 and VCO2 during the last three minutes of each exercise was used to calculate the EE during
walking and running. The EE difference from RMR (∆EE) for both exercises, and the relative ∆EE,
when expressed on body mass kilogram, were calculated.
2.3. Irisin Measurement
Venous blood samples were obtained directly before and 5 min after the last bout of physical
activity. After withdrawal, blood samples were centrifuged, serum collected, and stored at −80 ◦C until
analysis. The irisin concentration was determined using a commercial enzyme-linked immunosorbent
assay (ELISA) protocol (Irisin, Recombinant (Human, Mouse, Rat, Canine) (cat. no.: EK-067-29), range
0.1–1000 ng/mL, linear range 1.8–25.3 ng/mL, intra-assay variation: <10%, Phoenix Pharmaceuticals,
Inc., Burlingame, CA, USA), rated as the best among currently available ELISA kits [31]. The same
plate was used to analyze all irisin samples from each participant.
2.4. Statistical Analysis
In order to detect the presence of the outliers the interquartile range rule was used and data from
two female participants were excluded from the final analysis due to extreme outliers in resting energy
expenditure values in one, and in irisin levels in the other.
Statistical analysis was performed using SPSS Statistics v. 22.0 (IBM Corporation, USA) with
significance set at p < 0.05. The analysis included descriptive statistics for the entire sample, stratified
by sex in all cases. The results are presented as means and standard deviations or medians with
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interquartile ranges. Parameter differences between sexes were assessed using an independent samples
t-test in cases of Gaussian data distribution and the Mann–Whitney and Kruskal–Wallis tests in cases of
non-Gaussian data distribution. Spearman’s test was used to assess the correlation between variables.
3. Results
The study sample that was valid for analysis consisted of 84 participants and contained more
women (52%) than men. The mean age in both sexes was similar, but the height, body mass, and BMI
were significantly higher in the male group (p < 0.05 by independent-samples t-test), as shown in
Table 1.
Table 1. Anthropometric and body composition measurements of the study participants.
Variable (units)
Male
Mean ± SD (min–max)
n = 40
Female
Mean ± SD (min–max)
n = 44
Age (years) 31.2 ± 5.3 (21–46) 29.9 ± 6.4 (21–49)
Height (cm) 184 ± 7 (170–198) 169 ± 5 (158–188)
Body mass (kg) 81.5 ± 9.7 (63.7–99.4) 64.3 ± 7.6 (50.1–79.0)
BMI (kg/m2) 24.2 ± 2.5 (19.6–31.9) 22.3 ± 2.7 (17.6–29.7)
Total fat tissue (kg) 12.8 ± 5.2 (3.5–24.3) 15.6 ± 4.9 (8.5–27.9)
Body fat (% from body mass) 15.3 ± 5.1 (5.2–26.4) 23.9 ± 5.3 (15.0–35.7)
Visceral fat (rating) 1 3.0 (2.3–6.0) 2.0 (1.0–3.0)
Lean body mass (kg) 68.8 ± 6.7 (53.9–83.0) 48.7 ± 4.4 (39.9–60.9)
Total muscle tissue (kg) 65.3 ± 6.4 (51.2–79.0) 46.2 ± 4.2 (37.8–57.85)
1 Results presented as median with IQR.
The measured serum irisin levels were similar in males and females; however, the relative pre- and
post-exercise concentrations of irisin per body mass kg were higher in females (Table 2). There were
no statistically significant differences between the corresponding pre-exercise irisin and post-exercise
irisin results, neither in males nor in females (paired samples t-test, p > 0.05).









Pre-exercise irisin (ng/mL) 9.5 ± 1.9 9.9 ± 1.9 0.400
Post-exercise irisin (ng/mL) 9.6 ± 2.1 9.7 ± 2.0 0.943
Pre-exercise irisin per body mass kg (ng/mL) 0.12 ± 0.02 0.16 ± 0.03 <0.001
Post-exercise irisin per body mass kg (ng/mL) 0.12 ± 0.03 0.15 ± 0.03 <0.001
1 p-value shows differences between sexes (Mann–Whitney test).
Individual responses to exercise included no changes, or increased or decreased serum irisin
concentrations. To quantify the measured changes, ∆ irisin was calculated as (1)
∆ irisin = ([post-exercise irisin − pre-exercise irisin]/[pre-exercise irisin]) × 100% (1)
Depending on the ∆ irisin result, the study sample was divided into three groups (Figure 1A,B),
based on the cut-off value of the manufacturer’s defined precision range of intra-assay variation (<10%):
∆ irisin group I, if the post-exercise irisin concentration decreased by more than 10% with respect to the
pre-exercise value; ∆ irisin group II, if changes were in the range plus to minus 10%; and ∆ irisin group
III, if the post-exercise irisin concentration increased by more than 10% with respect to the pre-exercise
value. The ∆ irisin group II included 58% (n = 49) of participants (65%:52%, M:F), ∆ irisin group I
included 23% (n = 19) (15%:30%, M:F), and ∆ irisin group III included 19% (n = 16) of participants
(20%:18%, M:F).
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Figure 1. Change in blood irisin concentration after acute exercise in males (A) and females (B).
Initial correlation analysis revealed weak to moderate not statistically significant relationship
between lean tissue, LBMI, visceral fat range, and total pre- and post-exercise irisin concentrations.
Neither in males nor in females were clear relationships between BMI, body fat %, and irisin
conc ntrat ons d tected. In addition, no statist cally significa t differences in body composition
parameters were found between the three ∆ irisin groups (p > 0.05, Kruskal–Wallis test).
In order to test whether the relative pre-exercise irisin values per body mass kg were related
to body composition, Spearman’s correlation test was performed (Table 3). Only in females was a
negative association observed between LBMI and irisin. Furthermore, the percent of body lean tissue
correlated positively, while visceral fat rating correlated negatively with irisin concentration in both
males and females; however, only the male results were statistically significant. Association of BMI
and body fat % with irisin concentration was not analyzed, since the body mass was a confounder in
these relationships.




Per Body Mass kg
Female
Pre-Exercise Irisin (ng/mL)
Per Body Mass kg
LBMI (kg/m2) −0.15 −0.59 **
Lean tissue (% from body mass) 0.41 * 0.28
Visceral fat (rating) −0.52 ** −0.26
* p < 0.05, ** p ≤ 0.001.
First, energy expenditure results were analyzed between sexes using the Mann–Whitney test.
Compared to females, males demonstrated a higher RMR (1.4 ± 0.1 vs 1.0 ± 0.1 kcal/min, p < 0.0001),
walking EE (4.6 ± 0.5 vs 3.8 ± 0.6 kcal/min, p < 0.0001), running EE (11.7 ± 1.3 vs 9.7 ± 1.3 kcal/min,
p < 0.0 1), ∆ walking EE (3.3 ± 0.5 vs 2.7 ± 0.5 kcal/min), and ∆ running EE (10.4 ± 1.3 vs
8.7 ± 1.2 kcal/min, p < 0.0001), ∆ EE expenditures were calculated (2)
∆ walking EE = walking EE − RMR; ∆ running EE = running EE − RMR (2)
When the absolute values were expressed per body ass kg the outcome was the opposite in that
females used more energy in both walking and running exercise than males, and the difference was
statistically significant for both running EE per body mass kg (p = 0.04) and ∆ running EE per body
mass kg (p = 0.02). Spearman’s correlation test detected that in both sexes, the RMR per kg strongly
correlated with the percentage of lean tissue in the body (rho = 0.60 in males, rho = 0.57 in females;
p < 0.000).
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The relationship between irisin concentration and resting, walking, and running energy
expenditure parameters in both sex groups was found to be positively correlated with pre-exercise
irisin concentration per body mass kg and RMR value per body mass kg (Spearman’s rho = 0.44,
p = 0.004 in males; rho = 0.36, p = 0.016 in females) (Figure 2A,B).
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Furthermore, the pre-exercise irisin concentration per body mass kg positively correlated with
walking (rho = 0.32, p = 0.041), running (rho = 0.37, p = 0.018), and ∆ running EE (rho = 0.35, p = 0.028)
values per body mass kg in males only (Figure 3). The Kruskal–Wallis test and the following post-hoc
analysis found statistically significant differences in males bet een the values of running EE per
body mass kg and ∆ runni g E per bo s kg in the three ∆ irisin groups. Results showed that
the male participants in the ∆ isin group II had igher running EE per body mass kg (p = 0.042,
95% I = − .0004 to −0.0284) and ∆ running EE per body mass kg (p = 0.047, 95% CI = −0. 0015 to
−0.02707) than the ∆ irisin group I participants (Figure 4).
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4. Discussion
The current study investigated the irisin concentration in healthy adults of both sexes. Since the
pre-exercise irisin concentration was measured in blood samples obtained at the same time of day after
the standardized preparation of participants, the results could be interpreted as a typical, basal irisin
plasma concentration. Due to evidence that the irisin concentration may vary significantly depending
on the utilized type of commercial kit, comparison of the results is possible only with studies that use
the same type of kit. The average pre-exercise irisin level was consistent with the baseline level found
in healthy individuals in the KarMeN-study [32], in a study of adipose women of a similar age reported
by Winn et al. [33], a middle aged Chinese population [34], and even similar to the values measured
in pregnant women between the second and third trimester of normal gestation [35]. However, the
values that we report in the current study were almost 40 times lower than the baseline plasma irisin
level determined in a small study sample of similar characteristics in Norway [20], and slightly lower
than the baseline level detected in a group of adolescents [36]. In our study, there were no statistically
significant differences between absolute male and female irisin serum concentrations, in neither the
pre-exercise nor post-exercise blood sample. In the aforementioned studies (if measured), the baseline
irisin did not differ between sexes. A higher value of irisin was observed in females in the present
study when expressed per body mass kg and LBM, as was also observed in the study by Anastasilakis
and colleagues [14] suggesting a possible influence of sex-specific factors on irisin secretion.
In the current study, we found no significant relationship between total serum irisin concentration
and the amount of irisin producing body tissue—lean or fat body mass, neither in common nor in
sex-stratified correlation analysis. However, our results revealed that the specific interaction between
the basal irisin level per body mass kg, and the amount of a particular body tissue type in healthy
adults are directly correlated with lean body mass and inverse with fat tissue, notably with visceral
fat. These associations are in line with the findings of a cross-sectional study in Korean adults, which
confirmed the negative relationship between visceral fat and irisin, and that the higher skeletal muscle
mass to visceral fat area ratio was associated with higher irisin levels [37]. In rat models, it has been
demonstrated that adipose tissue, depending on the anatomical location, has distinct activity with
respect to irisin secretion, while the subcutaneous fat cells secrete considerably more circulating irisin
than visceral or fat cells in other locations [38]. To the best of our knowledge, there are no similar data
regarding human fat cells. However, if we assume that the same principle applies to humans, then the
lack of sex difference in absolute irisin concentration in the present study could be explained by the
typically increased subcutaneous fat mass in women, which may have led to higher secretory activity,
and resulted in higher irisin concentration expressed per body kg in females.
The current study demonstrated no association between total irisin concentration and BMI in both
sexes. As BMI is widely accepted as an indicator of healthy body composition, which increases mainly
due to body fat accumulation, the tendency could be in concordance with the statements that the
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primary source of circulating irisin is skeletal muscles, and to lesser extent, body fat tissue [38]. In obese
individuals, subcutaneous and visceral adipose tissue show decreased FNDC5 gene expression and
consequently lower concentrations of circulating irisin [28]. A number of previous studies, mainly
involving healthy participants within a normal BMI range, reported no association between irisin
and BMI [14,22]. Moreover, in a study with a control group, irisin positively correlated with BMI and
body fat in both subgroups, in runners with normal BMI and in controls with increased BMI [39].
In particular study groups—especially in those with overweight and obese participants [31], and also
across the groups with a wide BMI spectrum, including both anorexia nervosa and extremely adipose
patients—irisin levels directly correlated with body mass, BMI, fat, and fat-free mass [25,26], indicating
possible modification of irisin secretion from muscle and fat tissue when body metabolism and tissue
proportions are changed. Besides the isolated effect on irisin secretion, alterations in production of
many other myokines and adipokines, and their interaction on target cells have to be considered in
each case [4].
A direct association between RMR and pre-exercise irisin values when expressed per body mass
kg was the only significant relationship regarding energy metabolism that we observed in participants
of both sexes. These data support positive correlation between lean body mass, RMR, and irisin
secretion and can be attributed mainly to increased mitochondrial activity in skeletal muscles and
stimulation of thermogenesis lipolysis, as well as increased energy expenditure in adipose tissue [40].
The lack of association between irisin and exercise energy expenditure parameters in females might
indicate sex-related differences in the regulation of energetic metabolism. However, male subjects,
whose pre-exercise irisin concentration was greater, metabolized energy to a greater extent in order
to maintain walking and running activity. The most likely explanation would be irisin and energy
expenditure correlation with individual body mass, but this was not relevant in our results since values
per body mass kg were analyzed. In addition, other potential reasons—such as physical fitness status
and habitual PA—were not confirmed as determinants of basal irisin levels in various studies [14,32].
Moreover, in men, an inverse relationship between basal irisin and exercise capacity assessed by
peakVO2 was detected in large study involving healthy volunteers [41].
Despite the expected increase in irisin after exercise, our results for various ∆ irisin are in line
with the inconsistent findings of other studies that reported either no or various irisin concentration
changes immediately after exercise intervention [16,19]. Further detailed analysis of current ∆ irisin
data allowed us to conclude that in men there is a certain relationship between the direction of irisin
changes and energy expenditure. Respectively, male subjects without relevant differences between pre-
and post-exercise irisin levels (∆ irisin group II) used more kcal in running per body mass kg, and their
energy expenditure during running increased significantly more with respect to RMR than in those
whose irisin levels decreased after exercise bouts. This could be explained by increased expression of
various genes that are involved in cell energetics and mitochondrial biogenesis observed in in vitro
skeletal muscle cells incubated with irisin [3]. However, this study reported the results in animal cell
models, and the mechanism of irisin action in energetic metabolism in human real-body conditions
could be more complex and represents a challenge for further research.
Study Strengths and Limitations
One of the strengths of our study is that the selection of participants of both sexes allowed us to
compare responses in both males and females. Furthermore, since all participants were apparently
healthy, their body composition parameters were distributed around the range of normal values and
testing of all the subjects occurred following an identical protocol and at the same time of day. This
allowed us to interpret the pre-exercise irisin results as typical basal irisin concentrations for healthy
persons, and the secretion responses as typical to a given physical load. In our study, the resting
metabolic rate and energy expenditure were measured using indirect calorimetry which allowed us to
operate with the real data for our subjects. In addition, the irisin concentration was determined using a
test kit that is widely considered to be the most accurate. The lack of control group could be considered
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as one of the main limitations of our study. The availability of irisin results from control subjects in
corresponding time periods would prove whether the observed irisin concentration changes were only
exercise-induced or if they simply represented a natural fluctuation of irisin levels. Furthermore, the
method we used for irisin measurement in serum samples did not provide the option to differentiate
tissue circulating irisin or its fractions. Skeletal muscles in general are considered as the main secretory
tissues for irisin; however, other tissue types, particularly fat tissue, also produce irisin. This limits
our ability to provide a precise explanation of the origin of the irisin in different male and female
results relative to the muscle and fat mass. In addition, we were also unable to definitively confirm
which tissue type (skeletal muscle, subcutaneous, visceral fat) was predominantly responsible for the
observed correlations; assuming that each tissue type, in case their proportions are different, could alter
its secretory activity and lead to the observed associations with pre-exercise irisin concentration in men.
The final limiting factor is that we only used the post-exercise blood sample for irisin measurement,
which poses a question about the right time interval to assess irisin changes in blood after exercise.
5. Conclusions
The results of the current study suggest that the association of irisin concentration with body fat
and lean tissue amount has sex-dependent differences, and that acute exercise can lead to various
changes in irisin level in healthy adults. In participants of both sexes, a higher pre-exercise irisin
level was associated with a higher resting metabolic rate, while in males it was also associated with
higher energy expenditure during exercise. However, in males, no change in irisin levels after exercise
was related to higher running energy expenditure. Since the direction of this relationship is unclear,
and the magnitude of the changes of circulating irisin concentration could be considered functionally
significant, further studies are needed to determine the role and regulation of irisin in humans.
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Micielska, K.; Ziemann, E. Acute Postexercise Change in Circulating Irisin Is Related to More Favorable Lipid
Profile in Pregnant Women Attending a Structured Exercise Program and to Less Favorable Lipid Profile
in Controls: An Experimental Study with Two Groups. Int. J. Endocrinol. 2019, 2019, 1932503. [CrossRef]
[PubMed]
36. Blizzard LeBlanc, D.R.; Rioux, B.V.; Pelech, C.; Moffatt, T.L.; Kimber, D.E.; Duhamel, T.A.; Dolinsky, V.W.;
McGavock, J.M.; Sénéchal, M. Exercise-induced irisin release as a determinant of the metabolic response to
exercise training in obese youth: The EXIT trial. Physiol. Rep. 2017, 5, e13539. [CrossRef]
37. Hwang, Y.C.; Jeon, W.S.; Park, C.Y.; Youn, B.S. The ratio of skeletal muscle mass to visceral fat area is a main
determinant linking circulating irisin to metabolic phenotype. Cardiovasc. Diabetol. 2016, 15, 9. [CrossRef]
38. Roca-Rivada, A.; Castelao, C.; Senin, L.L.; Landrove, M.O.; Baltar, J.; Belen Crujeiras, A.; Seoane, L.M.;
Casanueva, F.F.; Pardo, M. FNDC5/irisin is not only a myokine but also an adipokine. PLoS ONE 2013,
8, e60563. [CrossRef]
39. Hew-Butler, T.; Landis-Piwowar, K.; Byrd, G.; Seimer, M.; Seigneurie, N.; Byrd, B.; Muzik, O. Plasma irisin in
runners and nonrunners: No favorable metabolic associations in humans. Physiol. Rep. 2015, 3. [CrossRef]
40. Arhire, L.I.; Mihalache, L.; Covasa, M. Irisin: A Hope in Understanding and Managing Obesity and Metabolic
Syndrome. Front. Endocrinol. 2019, 10, 524. [CrossRef]
41. Kerstholt, N.; Ewert, R.; Nauck, M.; Spielhagen, T.; Bollmann, T.; Stubbe, B.; Felix, S.B.; Wallaschofski, H.;
Gläser, S.; Friedrich, N. Association of circulating irisin and cardiopulmonary exercise capacity in healthy
volunteers: Results of the Study of Health in Pomerania. BMC Pulm. Med. 2015, 15, 41. [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
